The Life Sciences Discovery Fund (LSDF) in Seattle, Washington awarded some $600,000 in grants for the commercial development of technologies to improve the diagnosis and management of health conditions. LSDF is a Washington state agency that makes grant investments in life sciences research to benefit Washington state citizens.
Christopher Bernards at Benaroya Research Institute at Virginia Mason in Seattle received a $150,000 LSDF award to conduct first-in-human testing of a device that can deliver drugs directly to the central nervous system through an intranasal route. The new methods, if successful would be less risky, painful, and expensive than current techniques involving direct injections into the cerebrospinal fluid.
To read the full, original article click on this link: Life Science Commercialization Grants Awarded | Science Business - Connecting scientific discovery with the marketplace
